Soligenix Initiates Radiation Enteritis Prevention Moves | Radiology

Links shared publicly online about this topic.

  • 1,509
    total visits

Soligenix Initiates Radiation Enteritis Prevention Moves | Radiology

medicexchange.com

DOR BioPharma, Inc. announced that it has initiated a Phase 1/2 clinical trial evaluating SGX201, a time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP)

View full resource at medicexchange.com

Tags: Clinical Trial, Radiology, News, Radiation

  • Share

Most Recently Shared on December 23, 2009 at 6:00 pm By:

MedicExchange Alex van Klaveren

Latest News Soligenix Initiates Radiation Enteritis Prevention Moves: Soligenix, Inc. formerly kn... http://bit.ly/7s5Xxq MedicExchange.com

2 years ago...

Advertisement